Irene Norstedt

Acting Executive Director,

The IMI Governing Board appointed Irene Norstedt as Acting Executive Director of IMI as of 16 December 2014.

Irene Norstedt comes from the European Commission, where she was Head of the Innovative and Personalised Medicine Unit at the European Commission’s Directorate-General for Research and Innovation. She has been at the European Commission since 1996, and was instrumental in the creation of IMI back in 2008. Prior to joining the European Commission, she worked at Swedish life science company Biacore AB and at the Swedish embassy in London.

Irene Norstedt takes over from Michel Goldman, whose mandate as IMI Executive Director ended in December 2014. The recruitment of a new IMI Executive Director is ongoing; the deadline for applications was in July 2014.